Company profile
Cell Line Development | Advanced Instruments
Streamline the cell line development process, efficient collection of evidence for credible IND submissions. Click here to find out more.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
AP04 | Transaction MzQ0MzY4OTM0MGFkaXF6a2N4
Published 18 Nov 2024 10:22
AD01 | Transaction MzQ0MzY4OTEzNGFkaXF6a2N4
Published 18 Nov 2024 10:20
Company registered at Companies House
1 Apr 2017 to 30 Apr 2019
The aim of this project is to establish new and innovative approaches for the manufacture of high-value, genome-edited cell lines used in bio-medical research. Genome editing is rapidly becoming an essential tool in all segments of life sciences R&D, from basic research to drug discovery and diagnostics, therapeutics (incl. regenerative medicine), synthet...
